Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2017-04-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11010-017-3044-7PMID 28455789PMCID PMC5660673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex

  2018cited by this paper
• Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment

  2018cited by this paper
• Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle

  2018cited by this paper
• Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3

  2018cited by this paper
• An ubiquitin-binding molecule can work as an inhibitor of ubiquitin processing enzymes and ubiquitin receptors.

  2016cited by this paper
• β-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4*

  2016cited by this paper
• New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle

  2016cited by this paper
• Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function

  2015cited by this paper
• PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome

  2015influential reference
• Serum ubiquitin via CXC chemokine receptor 4 triggered cyclooxygenase-1 ubiquitination possibly involved in the pathogenesis of aspirin resistance

  2015cited by this paper
• CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin.

  2014cited by this paper
• Extracellular Ubiquitin Increases Expression of Angiogenic Molecules and Stimulates Angiogenesis in Cardiac Microvascular Endothelial Cells

  2014cited by this paper
• β-Arrestin1 and Distinct CXCR4 Structures Are Required for Stromal Derived Factor-1 to Downregulate CXCR4 Cell-Surface Levels in Neuroblastoma

  2014cited by this paper
• Targeted Delivery of Ubiquitin-Conjugated BH3 Peptide-Based Mcl-1 Inhibitors into Cancer Cells

  2014cited by this paper
• Correction to “International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors”

  2014cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

  2014cited by this paper
• Extracellular ubiquitin enhances the suppressive effects of regulatory T cells on effector T cell responses.

  2014cited by this paper
• The Ubiquitin–CXCR4 Axis Plays an Important Role in Acute Lung Infection–Enhanced Lung Tumor Metastasis

  2013cited by this paper
• Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling.

  2013cited by this paper
• Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification.

  2013cited by this paper
• Using chemical shift perturbation to characterise ligand binding.

  2013cited by this paper
• The CXC Chemokine Receptor 4 Ligands Ubiquitin and Stromal Cell-derived Factor-1α Function through Distinct Receptor Interactions*

  2011cited by this paper
• CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual‐tropic (R5/X4) HIV‐1 infection

  2011cited by this paper
• Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

  2010cited by this paper
• CXC Chemokine Receptor 4 Is a Cell Surface Receptor for Extracellular Ubiquitin*

  2010cited by this paper
• Differences in lysine pKa values may be used to improve NMR signal dispersion in reductively methylated proteins

  2009cited by this paper
• Regulation of CXCR4 signaling.

  2007cited by this paper
• Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.

  2004cited by this paper
• Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor*

  2004cited by this paper
• Ubiquitin expression is up-regulated in human and rat skeletal muscles during aging.

  2004cited by this paper
• β-Arrestin2 Is Critically Involved in CXCR4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of p38 MAPK Activation*

  2002cited by this paper
• Structural insights into substrate binding by the molecular chaperone DnaK

  2000cited by this paper
• Inhibition of G-protein-coupled Receptor Function by Disruption of Transmembrane Domain Interactions*

  1999cited by this paper
• Crystal structure of Aplysia ADP ribosyl cyclase, a homologue of the bifunctional ectozyme CD38

  1996cited by this paper
• A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

  1996cited by this paper
• Localizing the NADP+ binding site on the MurB enzyme by NMR

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper

• Extracellular Ubiquitin Drives M2 Macrophage Polarization in Multiple Myeloma Through JAK1/STAT3‐mediated Transcriptional Activation of CXCR4

  2025cites this paper
• Almost 50 Years of Monomeric Extracellular Ubiquitin (eUb)

  2024cites this paper
• α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation.

  2023cites this paper
• G protein activation via chemokine (C‐X‐C motif) receptor 4 and α1b‐adrenoceptor is ligand and heteromer‐dependent

  2023cites this paper
• Heteromerization between α1B‐adrenoceptor and chemokine (C‐C motif) receptor 2 biases α1B‐adrenoceptor signaling: Implications for vascular function

  2022cites this paper
• Novel AT1R-Allosteric Ligands Mask the Preeclampsia Auto-antibody Epitope and Decrease Angiotensin-induced Vasoconstriction

  2021cites this paper
• Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers

  2021cites this paper
• Class A G protein‐coupled receptors assemble into functional higher‐order hetero‐oligomers

  2021cites this paper
• Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4

  2020cites this paper
• Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia–reperfusion injury and hemorrhage

  2020cites this paper
• Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration

  2019cites this paper
• Mapping the intracellular molecular mechanisms of chemokine signalling within cancer

  2019cites this paper
• Biased Receptor Signaling in Drug Discovery

  2019cites this paper
• Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex

  2018cites this paper
• Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3

  2018cites this paper
• Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle

  2018cites this paper
• Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment

  2018cites this paper
• Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function

  2017cites this paper